People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Koios Medical, Inc. | — | Biotechnology | Series A | $16.0M | $948K | 2023 |
Christine Li Shuling at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christine Li Shuling on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Graham Anderson | 1 | 5 |
| Robert Chad McClennan | 1 | 1 |
| Gregory Chad Moran | 1 | 1 |
| Christine Chad Li | 1 | 1 |
| Mark Chad Glasgold | 1 | 1 |
| John Li Walker | 1 | 1 |
| Robert Li McClennan | 1 | 1 |
| Gregory Li Moran | 1 | 1 |
| Mark Li Glasgold | 1 | 1 |
| Gregory E. Moran | 1 | 1 |
| Mark E. Glasgold | 1 | 1 |
| William E. Peterson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.